Spineguard (France) Today

ALSGD Stock  EUR 0.20  0.00  0.00%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
Spineguard is selling at 0.2 as of the 26th of February 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.2. Spineguard has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. The company has 31.71 M outstanding shares. More on Spineguard

Moving against Spineguard Stock

  0.7CS AXA SA Earnings Call TomorrowPairCorr
  0.64RMS Hermes International SCAPairCorr
  0.62SAN Sanofi SAPairCorr
  0.57TTE TotalEnergies SEPairCorr
  0.55MC LVMH Mot HennessyPairCorr
  0.53CDI Christian Dior SEPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Spineguard Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Spineguard's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Spineguard or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
PresidentSteve McAdoo
Business ConcentrationHealth Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Spineguard (ALSGD) is traded on Euronext Paris in France and employs 21 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 33.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spineguard's market, we take the total number of its shares issued and multiply it by Spineguard's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Spineguard operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 31.71 M outstanding shares. Spineguard has accumulated about 1.06 M in cash with (1.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check Spineguard Probability Of Bankruptcy
Ownership Allocation
Spineguard shows a total of 31.71 Million outstanding shares. About 98.73 % of Spineguard outstanding shares are held by general public with 1.27 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Spineguard Ownership Details

Spineguard Risk Profiles

Although Spineguard's alpha and beta are two of the key measurements used to evaluate Spineguard's performance over the market, the standard measures of volatility play an important role as well.

Spineguard Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Spineguard without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Spineguard Corporate Executives

Elected by the shareholders, the Spineguard's board of directors comprises two types of representatives: Spineguard inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spineguard. The board's role is to monitor Spineguard's management team and ensure that shareholders' interests are well served. Spineguard's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spineguard's outside directors are responsible for providing unbiased perspectives on the board's policies.
Manuel LanfossiCFO, Member of the Management Board, IR Contact OfficerProfile

Additional Tools for Spineguard Stock Analysis

When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.